- $2.52bn
- $3.60bn
- CA$3.03bn
- 73
- 58
- 35
- 56
Annual income statement for ATS, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,430 | 1,430 | 2,183 | 2,577 | 3,033 |
Cost of Revenue | |||||
Gross Profit | 366 | 374 | 614 | 728 | 863 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,334 | 1,310 | 1,996 | 2,355 | 2,717 |
Operating Profit | 95.6 | 120 | 187 | 222 | 315 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 67.5 | 79.5 | 154 | 160 | 247 |
Provision for Income Taxes | |||||
Net Income After Taxes | 53 | 64.1 | 121 | 128 | 194 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 52.9 | 64.1 | 122 | 127 | 194 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 52.9 | 64.1 | 122 | 127 | 194 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.798 | 0.678 | 1.52 | 1.65 | 2.13 |